"Because we are in a health care setting, masks are still required in all facilities. Thank you for helping keep our patients and staff safe."

During the past decade, University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP) conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 16 clinical trials were completed, i.e. on average, 69.6% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 11 clinical trials were completed. i.e. 91.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP)" #1 sponsor was "Pfizer" with 18 trials, followed by "Cytokinetics" with 4 trials sponsored, "Impax Laboratories, LLC" with 2 trials sponsored, "Andromeda Biotech Ltd." with 1 trials sponsored and "Celcuity, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP)" #1 collaborator was "Astellas Pharma Inc" with 4 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP)" are "Amyotrophic Lateral Sclerosis" (3 trials), "Breast Cancer" (3 trials), "Melanoma" (2 trials), "Respiratory Tract Infection" (2 trials) and "Advanced Cancers" (1 trials). Many other conditions were trialed in "University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP)" in a lesser frequency.

Most popular intervention types in "University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP)" are "Drug" (26 trials), "Biological" (5 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Palbociclib" (3 trials), "Avelumab" (2 trials), "Binimetinib" (2 trials) and "Encorafenib" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP)" are 23 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP)". undefined are not yet recruiting, 4 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP), undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP), 7 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP) has several departments that took part in Clinical trials: "University of Colorado Cancer Center - Anschutz Cancer Pavilion" - 147 trials